Immuneel’s internationally-benchmarked CAR-T cell therapy for Non-Hodgkin’s Lymphoma, is one-tenth US cost: CEO

The company is working towards bringing the cost down further

from Business News Today, Latest Market News, Finance News https://ift.tt/X23YTNd
via IFTTT